Focal Nodular Hyperplasia: Follow-up

References

1. Craig JR, Peters RL, Edmondson HA, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer. Jul 15 1980;46(2):372-9. [Medline].

2. Wanless IR, Albrecht S, Bilbao J, Frei JV, Heathcote EJ, Roberts EA. Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol. Sep 1989;2(5):456-62. [Medline].

3. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology. Nov-Dec 1985;5(6):1194-200. [Medline].

4. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology. May 1990;11(5):787-97. [Medline].

5. Ndimbie OK, Goodman ZD, Chase RL, Ma CK, Lee MW. Hemangiomas with localized nodular proliferation of the liver. A suggestion on the pathogenesis of focal nodular hyperplasia. Am J Surg Pathol. Feb 1990;14(2):142-50. [Medline].

6. Rhodes RH, Marchildon MB, Luebke DC, Edmondson HA, Mikity VG. A mixed hamartoma of the liver: light and electron microscopy. Hum Pathol. Mar 1978;9(2):211-21. [Medline].

7. Saul SH. Masses of the liver. In: Sternberg SS, ed. Diagnostic Surgical Pathology. 2^nd ed. New York, NY: Raven; 1994:1517-1580.

8. Vilgrain V, Flejou JF, Arrive L, et al. Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology. Sep 1992;184(3):699-703. [Medline].

9. Klatskin G. Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology. Aug 1977;73(2):386-94. [Medline].

10. Knowles DM, Wolff M. Focal nodular hyperplasia of the liver: a clinicopathologic study and review of the literature. Hum Pathol. Sep 1976;7(5):533-45. [Medline].

11. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. Aug 17 1979;242(7):644-8. [Medline].

12. Christopherson WM, Mayt ET, Barrows GH. Liver tumors in young women: a clinical pathologic study of 201 cases in the Louisville registry. In: Fenoglio C, Wolf M, eds. Progress in Strategical Pathology. vol 2. New York, NY: Masson; 1980:187-205.

13. Knowles DM 2nd, Casarella WJ, Johnson PM, Wolff M. The clinical, radiologic, and pathologic characterization of benign hepatic neoplasms. Alleged association with oral contraceptives. Medicine (Baltimore). May 1978;57(3):223-37. [Medline].

14. Mariani AF, Livingstone AS, Pereiras RV Jr, van Zuiden PE, Schiff ER. Progressive enlargement of an hepatic cell adenoma. Gastroenterology. Dec 1979;77(6):1319-25. [Medline].

15. Pain JA, Gimson AE, Williams R, Howard ER. Focal nodular hyperplasia of the liver: results of treatment and options in management. Gut. May 1991;32(5):524-7. [Medline].

16. Ishak KG. Hepatic neoplasms associated with contraceptive and anabolic steroids. In: Lingemen CH, ed. Recent Results in Cancer Research. Berlin, Germany: Springer-Verlag; 1979:73.

17. Kerlin P, Davis GL, McGill DB, Weiland LH, Adson MA, Sheedy PF 2nd. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology. May 1983;84(5 Pt 1):994-1002. [Medline].

18. Nguyen BN, Fléjou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol. Dec 1999;23(12):1441-54. [Medline].

19. Paradis V, Benzekri A, Dargère D, Bièche I, Laurendeau I, Vilgrain V. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology. May 2004;126(5):1323-9. [Medline].

20. Carlson SK, Johnson CD, Bender CE, Welch TJ. CT of focal nodular hyperplasia of the liver. AJR Am J Roentgenol. Mar 2000;174(3):705-12. [Medline].

21. Kubaska S, Sahani DV, Saini S, et al. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization. Clin Radiol. May 2001;56(5):410-5. [Medline].

22. Uggowitzer MM, Kugler C, Mischinger HJ, et al. Echo-enhanced Doppler sonography of focal nodular hyperplasia of the liver. J Ultrasound Med. Jul 1999;18(7):445-51; quiz 453-4. [Medline].

23. Lee IJ, Jeong SH, Choi JW, Park HS, Lee KH, Kim H. Radiological findings in a case of multiple focal nodular hyperplasia associated with portal vein atresia and portopulmonary hypertension. Korean J Radiol. Aug 2008;9(4):386-9. [Medline].

24. Dähnert W. Disorders of liver, biliary tract and spleen. In: Radiology Review Manual. 6th Edition. Philadelphia, Pa: Wolters Kluwer Health; 2006:714-715.

25. Semelka RC, Martin DR, Balci C, Lance T. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging. Mar 2001;13(3):397-401. [Medline].

26. Sudour H, Mainard L, Baumann C, Clement L, Salmon A, Bordigoni P. Focal nodular hyperplasia of the liver following hematopoietic SCT. Bone Marrow Transplant. Sep 22 2008;[Medline].

27. Attal P, Vilgrain V, Brancatelli G, Paradis V, Terris B, Belghiti J. Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases. Radiology. Aug 2003;228(2):465-72. [Medline].

28. Shen YH, Fan J, Wu ZQ, Ma ZC, Zhou XD, Zhou J. Focal nodular hyperplasia of the liver in 86 patients. Hepatobiliary Pancreat Dis Int. Feb 2007;6(1):52-7. [Medline].

29. Tello R, Fenlon HM, Gagliano T, et al. Prediction rule for characterization of hepatic lesions revealed on MR imaging: estimation of malignancy. AJR Am J Roentgenol. Apr 2001;176(4):879-84. [Medline].

30. Hong HS, Kim HS, Kim MJ, De Becker J, Mitchell DG, Kanematsu M. Single breath-hold multiarterial dynamic MRI of the liver at 3T using a 3D fat-suppressed keyhole technique. J Magn Reson Imaging. Aug 2008;28(2):396-402. [Medline].

31. Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol. Jul 2008;43(7):504-11. [Medline].

32. Venkatesh SK, Yin M, Glockner JF, Takahashi N, Araoz PA, Talwalkar JA, et al. MR elastography of liver tumors: preliminary results. AJR Am J Roentgenol. Jun 2008;190(6):1534-40. [Medline].

33. Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol. Jul 2008;43(7):504-11. [Medline].

34. Marin D, Brancatelli G, Federle MP, Lagalla R, Catalano C, Passariello R, et al. Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media. Clin Radiol. May 2008;63(5):577-85. [Medline].

35. De Gaetano A, De Franco A, Maresca G, et al. [The integrated diagnosis of hepatic focal nodular hyperplasia: echography, color Doppler, computed tomography and magnetic resonance compared]. Radiol Med (Torino). Mar 1996;91(3):258-69. [Medline].

36. Uggowitzer M, Kugler C, Machan L, et al. Power Doppler imaging and evaluation of the resistive index in focal nodular hyperplasia of the liver. Abdom Imaging. May-Jun 1997;22(3):268-73. [Medline].

37. Ungermann L, Eliáš P, Zižka J, Ryška P, Klzo L. Focal nodular hyperplasia: Spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography. Eur J Radiol. Mar 10 2007;[Medline].

38. Boulahdour H, Cherqui D, Charlotte F, et al. The hot spot hepatobiliary scan in focal nodular hyperplasia. J Nucl Med. Dec 1993;34(12):2105-10. [Medline].

39. Caseiro-Alves F, Zins M, Mahfouz A-E, et al. Calcification in focal nodular hyperplasia: a new problem for differentiation from fibrolamellar hepatocellular carcinoma. Radiology. Mar 1996;198(3):889-92. [Medline].

40. Cherqui D, Rahmouni A, Charlotte F, et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology. Dec 1995;22(6):1674-81. [Medline].

41. Myers RP, Downey D, Chakrabarti S, Marotta PJ. Multiple focal nodular hyperplasia and steatosis: Atypical imaging characteristics. Can J Gastroenterol. Feb 2001;15(2):137-42. [Medline].

Further Reading

Guidelines and clinical studies:

Procedure guideline for hepatic and splenic imaging 3.0. Society of Nuclear Medicine, Inc.  1999 Feb (revised 2003 Jul 20).  5 pages.  NGC:003579

ACR Appropriateness Criteria® liver lesion characterization. American College of Radiology.  1998 (revised 2006).  7 pages.  NGC:005115

A Comparison of Contrast Enhanced Ultrasound (CEUS) and Contrast Enhanced Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) for Characterization of Focal Liver Masses

Keywords

focal nodular hyperplasia, FNH, liver tumors, hepatic tumors, Kupffer cells, Kupffer's hepatic central stellate scar

Contributor Information and Disclosures

Author

Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, LRCP, Chairman of Medical Imaging, Professor of Radiology, NGHA, King Fahad National Guard Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia
Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, LRCP is a member of the following medical societies: American Institute of Ultrasound in Medicine, Radiological Society of North America, Royal College of Physicians, Royal College of Physicians and Surgeons of the United States, Royal College of Radiologists, and Royal College of Surgeons of England
Disclosure: Nothing to disclose.

Coauthor(s)

Sumaira MacDonald, MBChB, PhD, MRCP, FRCR, Lecturer, Sheffield University Medical School; Endovascular Fellow, Sheffield Vascular Institute
Sumaira MacDonald, MBChB, PhD, MRCP, FRCR is a member of the following medical societies: British Medical Association, Royal College of Physicians, and Royal College of Radiologists
Disclosure: Nothing to disclose.

Colm Boylan, MB, BCh, MRCP, FRCR, Assistant Professor of Radiology, McMaster University; Staff Radiologist, St Joseph's Hospital, Canada
Colm Boylan, MB, BCh, MRCP, FRCR is a member of the following medical societies: Royal College of Radiologists
Disclosure: Nothing to disclose.

Muhammad Sohaib, MBBS, MSc, Senior Medical Officer, Assistant Professor, Department of Medical Sciences, Pakistan Institute of Engineering and Applied Sciences
Disclosure: Nothing to disclose.

Durre Sabih, MBBS, MSc, Visiting Faculty, Department of Nuclear Medicine, Pakistan Institute Applied Sciences and Nishtar Medical College; Director, Multan Institute of Nuclear Medicine and Radiotherapy
Disclosure: Nothing to disclose.

David Sherlock, MBBS, FRCS, Consulting Staff, Department of Surgery, North Manchester General Hospital, Christie Hospital
Disclosure: Nothing to disclose.

Chi-Leung (Eddie) Tam, MB, ChB, FRCS, Consulting Staff, Department of Radiology, Lancaster Royal Infirmary, UK
Chi-Leung (Eddie) Tam, MB is a member of the following medical societies: Royal College of Radiologists
Disclosure: Nothing to disclose.

Aali J Sheen, MD, MBChB, FRCS, Consulting Hepatobiliary Surgeon, HepatoBiliary Unit, Manchester Royal Infirmary
Aali J Sheen, MD, MBChB, FRCS is a member of the following medical societies: British Medical Association, International Hepato-Pancreato-Biliary Association, and Royal College of Surgeons of England
Disclosure: Nothing to disclose.

Medical Editor

John L Haddad, MD, Clinical Associate Professor, Department of Radiology, Weill Medical College of Cornell University; Director of Body MRI, Department of Radiology, Methodist Hospital in Houston
John L Haddad, MD is a member of the following medical societies: American College of Radiology, American Medical Association, and Radiological Society of North America
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

Udo P Schmiedl, MD, PhD, Clinical Professor, Department of Radiology, University of Washington; Consulting Staff, Swedish Medical Center, University of Washington Medical Center, Seattle Radiologists
Udo P Schmiedl, MD, PhD is a member of the following medical societies: American College of Radiology and Radiological Society of North America
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

John Karani, MBBS, FRCR, Consulting Staff, Department of Radiology, King's College Hospital, London
Disclosure: Nothing to disclose.